BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• 

  Business

  Bryologyx Names David Crockford Vice President Of Clinical Development And Logistics

  BryoLogyx Inc., announced that David Crockford has joined the Company as vice president of clinical development and logistics, a new position.

  February 5, 2020

   · 

  2 min read
• Business

  Accumen’s 3DR Labs Partners with Resonance Health to Expand its MRI Analysis Services

  3DR Labs will employ Resonance Health’s FerriSmart® software to analyze liver iron concentrations from MRIs and provide summary reports

  February 5, 2020

   · 

  5 min read
• 

  Business

  Cellectricon and StressMarq Biosciences collaborate to develop next generation reagents and assays to advance neurodegenerative disease research

  Cellectricon, a collaborative services provider dedicated to advancing drug discovery and research in the areas of chronic pain and neurodegenerative diseases announces a collaboration with StressMarq Biosciences.

  February 5, 2020

   · 

  2 min read
• 

  Biotech Bay

  Aimmune to Advance Development of Newly-Licensed Asset with $200 Million Investment from Nestle

  Aimmune announced a licensing deal with Xencor for the investigational humanized monoclonal antibody XmAb7195, which has been redubbed AIMab7195.

  February 5, 2020

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  BioSpace Global Roundup: Feb. 6

  Pharma and life science companies from across the globe provide updates on their pipelines and businesses.

  February 5, 2020

   · 

  5 min read

   · 

  Alex Keown
• Deals

  Ophthalmic gene therapy company Ikarovec launches with £2.5m seed funding

  Founded by UKI2S with co-investment from LifeArc & Parkwalk to advance a diabetic macular edema gene therapy and other pipeline products

  February 5, 2020

   · 

  6 min read
• 

  BioForest

  Be Cool Pharmaceutics Licences First in Class Thermolytic - First Step Towards Human Hibernation

  Be Cool Pharmaceutics LLC announced that they have obtained an exclusive license to a drug-composition patent which provides the capability of inducing a hibernation-like state.

  February 5, 2020

   · 

  1 min read
• 

  Business

  Merck Announces Major Spinoff of Women’s Health, Biosimilars and Legacy Products

  It plans to launch a new, independent, publicly-traded company to handle those products. No name for the new company has been announced.

  February 5, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Policy

  China’s Wuhan Institute Files to Patent the Use of Gilead’s Remdesivir for Coronavirus

  The Wuhan Institute of Virology, part of the China Academy of Sciences, has applied to patent the use of Gilead Sciences’ remdesivir to treat the current coronavirus outbreak.

  February 5, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  GSK Sets Plan to Split the Company into Two Separate Entities

  One entity will focus on pharmaceuticals and drug development, while the other will be aimed at consumer healthcare.

  February 5, 2020

   · 

  3 min read

   · 

  Alex Keown